isoproterenol has been researched along with eplerenone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hori, Y; Hoshi, F; Itoh, N; Kanai, K; Saitoh, R; Touei, D; Yamagishi, M | 1 |
1 review(s) available for isoproterenol and eplerenone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for isoproterenol and eplerenone
Article | Year |
---|---|
The Aldosterone Receptor Antagonist Eplerenone Inhibits Isoproterenol-Induced Collagen-I and 11β-HSD1 Expression in Rat Cardiac Fibroblasts and the Left Ventricle.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenergic beta-Agonists; Animals; Cells, Cultured; Collagen Type I; Eplerenone; Fibroblasts; Fibrosis; Heart Ventricles; Isoproterenol; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred WKY; Spironolactone | 2017 |